SCHEMBL1031574

SCHEMBL1031574

CCCNCCOc1ccc(NS(=O)(=O)c2ccc(OC(F)(F)F)cc2)c(C)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR9 P51686 5/20 0.44
FFAR4 Q5NUL3 1/20 0.44
TP53 P04637 1/20 0.41
SLC40A1 Q9NP59 1/20 0.38
PKM P14618 2/20 0.38
RORC P51449 1/20 0.38
HDAC3 O15379 2/20 0.38
HDAC4 P56524 2/20 0.38
HDAC1 Q13547 2/20 0.38
HDAC7 Q8WUI4 2/20 0.38
HDAC2 Q92769 2/20 0.38
HDAC10 Q969S8 2/20 0.38
HDAC11 Q96DB2 2/20 0.38
HDAC8 Q9BY41 2/20 0.38
HDAC6 Q9UBN7 2/20 0.38
HDAC9 Q9UKV0 2/20 0.38
HDAC5 Q9UQL6 2/20 0.38
SQSTM1 Q13501 1/20 0.38
KEAP1 Q14145 1/20 0.38
NFE2L2 Q16236 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4246509 0.99 CCR9 (0.44) CCR9FFAR4TP53SLC40A1PKM
SCHEMBL1033616 0.89 PKM (0.39) TP53PKMSQSTM1KEAP1NFE2L2
SCHEMBL1031476 0.89 FFAR4 (0.40) CCR9FFAR4TP53SLC40A1HDAC3
Hydrochloric Acid SCHEMBL4240512 0.89 PKM (0.39) TP53PKMSQSTM1KEAP1NFE2L2
Hydrochloric Acid SCHEMBL4240168 0.88 FFAR4 (0.40) CCR9FFAR4TP53SLC40A1HDAC3
SCHEMBL1033689 0.87 PKM (0.43) TP53PKMSQSTM1KEAP1NFE2L2
SCHEMBL1029498 0.86 KIT (0.41) TP53PKMSQSTM1KEAP1NFE2L2
Hydrochloric Acid SCHEMBL4251154 0.86 PKM (0.42) TP53PKMSQSTM1KEAP1NFE2L2
Hydrochloric Acid SCHEMBL4243947 0.85 KIT (0.41) TP53PKMSQSTM1KEAP1NFE2L2
SCHEMBL1033640 0.85 PKM (0.39) TP53PKMSQSTM1KEAP1NFE2L2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2013179-B1 ARYLOXYETHYLAMINE COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE DOPAMINE D3 RECEPTOR ABBOTT GMBH & CO KG (DE) 2011-01-19 EP disclosed